Hostname: page-component-7bb8b95d7b-s9k8s Total loading time: 0 Render date: 2024-09-21T09:28:12.670Z Has data issue: false hasContentIssue false
  • English
  • Français

Extrapyramidal side-effects and clinical response during acute neuroleptic treatment of schizophrenia

Published online by Cambridge University Press:  16 April 2020

F Benazzi
F Benazzi*
Affiliation:
Psychiatry Service, Public Hospital Morgagni, 47100Forli, Italy
*
*Correspondence and reprints: via Pozzetto 17, 48010 Casliglione di Cervia RA, Italy

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter to the Editor
Information
European Psychiatry , Volume 7 , Issue 2 , 1992 , pp. 95 - 96
Copyright
Copyright © Elsevier, Paris 1992

References

Kay, SROpler, LALindenmayer, JP (1989) The positive and negative syndrome scale (PANSS). Rationale and standardization Br J Psychiatry 155 (suppl), 59–65CrossRefGoogle Scholar
Levinson, DFSimpson, GMSingh, HYadalam, KJain, AStephanos, MJSilver, P (1990) Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment Arch Gen Psychiatry 47, 761–768CrossRefGoogle ScholarPubMed
Overall, JEGorham, DP (1962) The brief psychiatric rating scale (BPRS) Psychol Rep 10, 799–812CrossRefGoogle Scholar
Rifkin, ADoddi, SKarajgi, BBorenstein, MWachspress, M (1991) Dosage of haloperidol for schizophrenia Arch Gen Psychiatry 48, 166–170CrossRefGoogle Scholar
Simpson, GMAngus, JWS (1970) A rating scale for extrapyramidal side-effects Acta Psychiatr Scand 212, 11–19CrossRefGoogle ScholarPubMed
Van Putten, TMarder, SRMintz, J (1990) A controlled dose comparison of haloperidol in newly admitted schizophrenic patients Arch Gen Psychiatry 47, 754–758CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.